Fig. 1From: Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective studyFlowchart of the operational mode for patient inclusion. AD Alzheimer’s disease, CSF cerebrospinal fluid, FTD frontotemporal dementia, MCI mild cognitive impairmentBack to article page